FDA Accepts GW Pharma's Epidiolex NDA With Priority Review for Lennox-Gastaut Syndrome and Dravet…
The PDUFA goal date for completion of the FDA review of the Epidiolex NDA is June 27, 2018.
Source: BioSpace
The PDUFA goal date for completion of the FDA review of the Epidiolex NDA is June 27, 2018.
Source: BioSpace